Time out based discipline strategy for children's non-compliance with cystic fibrosis treatment

Catherine B McClellan1, Lindsey L Cohen, Kathryn Moffett

  • 1Department of Psychology, University of South Carolina, Columbia, SC 29208, USA. mcclellb@gwm.sc.edu

Insights

A time out discipline strategy improved treatment compliance in children with cystic fibrosis (CF). Parents reported fewer behavior problems and preferred this strategy for managing CF treatment adherence.

Area of Science:

  • Pediatric Psychology
  • Behavioral Medicine
  • Cystic Fibrosis Research

Background:

  • Children with cystic fibrosis (CF) often exhibit non-compliant behavior, leading to treatment avoidance.
  • Effective behavior management strategies are crucial for ensuring adherence to life-extending CF treatments.
  • Parental stress and burden can be exacerbated by challenges in managing pediatric treatment regimens.

Observation:

  • A single-subject reversal design was employed to assess a time out based discipline strategy.
  • Compliance with CF treatments was observed before and during the implementation of the time out strategy.
  • Parental reports on child behavior problems and preference for the intervention were collected.

Findings:

  • Children demonstrated significantly greater compliance with treatments when the time out strategy was applied.
  • Parents reported a reduction in treatment-related behavior problems and a decreased need for professional assistance.
  • Parents expressed a preference for the time out strategy over their usual child management methods.

Implications:

  • The time out strategy offers a practical and effective brief intervention for enhancing pediatric treatment adherence.
  • This approach may reduce the need for extensive parent-therapist interactions, benefiting families with demanding CF care schedules.
  • Further research is warranted to replicate these findings and confirm the long-term efficacy of this intervention.
Abstract

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Operant Conditioning Intervention01:24

Operant Conditioning Intervention

Operant conditioning serves as a foundational principle in therapeutic interventions aimed at modifying maladaptive behaviors. Central to this approach is the notion that behaviors, both adaptive and maladaptive, are learned through reinforcement. By analyzing the environmental factors that reinforce problematic behaviors, clinicians can design interventions to weaken these reinforcements and replace maladaptive behaviors with healthier alternatives.
In operant conditioning, behaviors that are...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...